Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX
- 13 November 2003
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (1), 217-223
- https://doi.org/10.1016/j.bmcl.2003.09.062
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Anticancer and Antiviral SulfonamidesCurrent Medicinal Chemistry, 2003
- Indisulam: an anticancer sulfonamide in clinical developmentExpert Opinion on Investigational Drugs, 2003
- Carbonic anhydrase inhibitorsMedicinal Research Reviews, 2002
- Sulfonamides and Sulfonylated Derivatives as Anticancer AgentsCurrent Cancer Drug Targets, 2002
- Applications of carbonic anhydrase inhibitors and activators in therapyExpert Opinion on Therapeutic Patents, 2002
- Carbonic Anhydrase InhibitorsCurrent Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, 2001
- E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivoEuropean Journal of Cancer, 2001
- Novel sulphonamide derivatives for the treatment of cancerExpert Opinion on Therapeutic Patents, 2000
- Carbonic anhydrase inhibitors and their therapeutic potentialExpert Opinion on Therapeutic Patents, 2000
- Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell CycleJournal of Medicinal Chemistry, 1999